Work

Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/α-interferon

Year: 1998

Type: article

Source: Medical Oncology

DOI: 10.1007/bf02821938

Authors: R Katherine Alpaugh, Margaret von Mehren, Irma Palazzo, Michael B Atkins, Joseph A Sparano, Lynn Schuchter, Louis M Weiner, Janice P Dutcher

Institutions: Fox Chase Cancer Center, Jeanes Hospital, Tufts University, Tufts Medical Center, Albert Einstein College of Medicine, Montefiore Medical Center, Montefiore Einstein Comprehensive Cancer Center, University of Pennsylvania

Language: English

Topic: Cutaneous Melanoma Detection and Management

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G1042980396, Eastern Cooperative Oncology Group, Comprehensive Cancer Center Program at Fox Chase, G921727105

OpenAlex ID: W1981743199

FWCI: 0.422

Cites: 24

Cited by: 24

Related to: 10